The Gross Margin of CanSino Biologics Inc (688185.SS) is 69.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 69.60% |
| 2023-12-31 | -124.27% |
| 2022-12-31 | -17.76% |
| 2021-12-31 | 69.82% |
| 2020-12-31 | 25.57% |